↓ Skip to main content

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial

Overview of attention for article published in Cardiovascular Diabetology, April 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (58th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
168 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
Published in
Cardiovascular Diabetology, April 2017
DOI 10.1186/s12933-017-0532-8
Pubmed ID
Authors

Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Isao Taguchi, Minako Yamaoka-Tojo, Hirofumi Tomiyama, Hiroki Teragawa, Seigo Sugiyama, Hisako Yoshida, Yasunori Sato, Atsushi Kawaguchi, Yumi Ikehara, Noritaka Machii, Tatsuya Maruhashi, Kosuke R. Shima, Toshinari Takamura, Yasushi Matsuzawa, Kazuo Kimura, Masashi Sakuma, Jun-ichi Oyama, Teruo Inoue, Yukihito Higashi, Shinichiro Ueda, Koichi Node

Mendeley readers

The data shown below were compiled from readership statistics for 168 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 168 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 24 14%
Researcher 20 12%
Student > Master 17 10%
Other 15 9%
Student > Ph. D. Student 12 7%
Other 31 18%
Unknown 49 29%
Readers by discipline Count As %
Medicine and Dentistry 69 41%
Nursing and Health Professions 18 11%
Pharmacology, Toxicology and Pharmaceutical Science 11 7%
Biochemistry, Genetics and Molecular Biology 5 3%
Agricultural and Biological Sciences 4 2%
Other 9 5%
Unknown 52 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2019.
All research outputs
#5,618,073
of 17,388,379 outputs
Outputs from Cardiovascular Diabetology
#322
of 1,002 outputs
Outputs of similar age
#160,385
of 392,469 outputs
Outputs of similar age from Cardiovascular Diabetology
#45
of 127 outputs
Altmetric has tracked 17,388,379 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,002 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,469 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.
We're also able to compare this research output to 127 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.